Improved patient-reported functional outcomes after nerve-sparing radical prostatectomy by using NeuroSAFE technique

References

• Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol. 1998; 160:2418.
   PubMed Web of Science ®Google Scholar
• Preisser F, Mazzone E, Knipper S, et al. Rates of positive surgical margins and their effect on cancer-specific mortality at radical prostatectomy for patients with clinically localized prostate cancer. Clin Genitourin Cancer. 2019;17(1):e130.
   PubMed Web of Science ®Google Scholar
• Nguyen LN, Head L, Witiuk K, et al. The risks and benefits of cavernous neurovascular bundle sparing during radical prostatectomy: a systematic review and meta-analysis. J Urol. 2017;198(4):760.
   PubMed Web of Science ®Google Scholar
• Khoder WY, Waidelich R, Buchner A, et al. Prospective comparison of one year follow-up outcomes for the open complete intrafascial retropubic versus interfascial nerve-sparing radical prostatectomy. Springerplus. 2014;3(1):335.
   PubMedGoogle Scholar
• Nunez AL, Giannico GA, Mukhtar F, et al. Frozen section evaluation of margins in radical prostatectomy specimens: a contemporary study and literature review. Ann Diagn Pathol. 2016; 24:11.
   PubMed Web of Science ®Google Scholar
• Vasdev N, Agarwal S, Rai BP, et al. Intraoperative frozen section of prostate reduces the risk of positive margin whilst ensuring nerve sparing in patients with imtermediate and high-risk prostate cancer undergoing robotic radical prostatectomy: first reported UK series. Curr Urol. 2015;9(2):93.
   Google Scholar
• Stolzenburg JU, Kallidonis P, Do M, et al. A comparison of outcomes for interfascial and intrafascial nerve-sparing radical prostatectomy. Urology. 2010;76(3):743.
   PubMed Web of Science ®Google Scholar
• Schlomm T, Tennstedt P, Huxhold C, et al. Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11 069 consecutive patients. Eur Urology. 2012;62(2):333.
   PubMed Web of Science ®Google Scholar
• Beyer B, Schlomm T, Tennstedt P, et al. A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomy. Eur Urology. 2014;66(1):138.
   PubMed Web of Science ®Google Scholar
• Mirmilstein GBP, Gbolahan O, Srirangam V, et al. The neurovascular structure-adjacent frozen-section examination (NeuroSAFE) approach to nerve sparing in robot-assisted laparoscopic radical prostatectomy in a British setting – a prospective observational comparative study. BJU Int. 2018;121(6):854.
   PubMed Web of Science ®Google Scholar
• Berge V, Berg RE, Hoff JR, et al. A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-up. Urology. 2013;81(4):781.
   PubMed Web of Science ®Google Scholar
• Storås AH, Sanda MG, Boronat OG, et al. Erectile dysfunction and sexual problems two to three years after prostatectomy among American, Norwegian, and Spanish Patients. Clin Genitourin Cancer. 2016;14(3):e265.
   PubMed Web of Science ®Google Scholar
• Brennhovd B, Axcrona K, Fosså SD, et al. Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: a controlled study of operative and short-term postoperative events. Scand J Urol. 2013;47(6):449.
   PubMed Web of Science ®Google Scholar
• Fosså SD, Storås AH, Steinsvik EA, et al. Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26). Scand J Urol. 2016;50(4):280.
   PubMed Web of Science ®Google Scholar
• Ware JE, Keller SD, Kosinski M. How to score the SF-12 physical and mental health summary scales. Boston (MA): New England Medical Center Health Institute; 1998.
   Google Scholar
• Denolett J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005; 67:89–97.
   PubMed Web of Science ®Google Scholar
• D’Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998; 280:969.
   PubMed Web of Science ®Google Scholar
• http://www-01.ibm.com/support/docview.wss?uid=swg21476197.
   Google Scholar
• http://www.stata.com/support/faqs/resources/citing-software-documentation-faqs/.
   Google Scholar
• Salonia A, Burnett AL, Graefen M, et al. Prevention and management of postprostatectomy sexual dysfunction part 1: choosing the right patient at the right time for the right surgery. Eur Urol. 2012;62(2):261.
   PubMed Web of Science ®Google Scholar
• Steineck G, Bjartell A, Hugosson J, et al. Degree of preservation of the neurovascular bundles during radical prostatectomy and urinary continence 1 year after surgery. Eur Urol. 2015;67(3):559.
   PubMed Web of Science ®Google Scholar
• Montorsi F, McCullough A. Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med. 2005;2(5):658.
   PubMed Web of Science ®Google Scholar
• Capogrosso P, Vertosick EA, Benfante NE, et al. Are we improving erectile function recovery after radical prostatectomy? Analysis of patients treated over the last decade. Eur Urol. 2019;75(2):221.
   PubMed Web of Science ®Google Scholar
• Goonewardene SS, Cahill D. What is the role of Neurosafe in robotic radical prostatectomy?. J Robotic Surg. 2019;13(1):187.
   PubMed Web of Science ®Google Scholar
• Schlomm T, Heinzer H, Steuber T, et al. Full functional-length urethral sphincter preservation during radical prostatectomy. Eur Urol. 2011;60(2):320.
   PubMed Web of Science ®Google Scholar
• Pompe RS, Krüger A, Preisser F, et al. The impact of anxiety and depression on surgical and functional outcomes in patients who underwent radical prostatectomy. Eur Urol Focus. 2018;18:S2405–4569.
   Google Scholar
• Punnen S, Cowan JE, Dunn LB, et al. A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer. BJU Int. 2013;112(2):E67.
   PubMed Web of Science ®Google Scholar
• Tavlarides AM, Ames SC, Diehl NN, et al. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. Psychooncology. 2013;22(6):1328.
   PubMed Web of Science ®Google Scholar
• Mohamed NE, Bovbjerg DH, Montgomery GH, et al. Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer. Urol Oncol. 2012;30(6):804.
   PubMed Web of Science ®Google Scholar
• Dieperink KB, Hansen S, Wagner L, et al. Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer. Acta Oncol. 2012;51(6):722.
   PubMed Web of Science ®Google Scholar